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Zika virus (ZIKV), an arbovirus of global concern, remodels intracellular membranes to form
replication sites. How ZIKV dysregulates lipid networks to allow this, and consequences for
disease, is poorly understood. Here, we perform comprehensive lipidomics to create a lipid
network map during ZIKV infection. We find that ZIKV significantly alters host lipid com-
position, with the most striking changes seen within subclasses of sphingolipids. Ectopic
expression of ZIKV NS4B protein results in similar changes, demonstrating a role for NS4B in
modulating sphingolipid pathways. Disruption of sphingolipid biosynthesis in various cell
types, including human neural progenitor cells, blocks ZIKV infection. Additionally, the
sphingolipid ceramide redistributes to ZIKV replication sites, and increasing ceramide levels
by multiple pathways sensitizes cells to ZIKV infection. Thus, we identify a sphingolipid
metabolic network with a critical role in ZIKV replication and show that ceramide flux is a key
mediator of ZIKV infection.
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ika virus (ZIKV), an enveloped positive-strand RNA virus
of the family Flaviviridae, has recently emerged as a sig-
nificant global human health threat1. Following its rapid
expansion into the Americas, ZIKV has been found to possess a
unique combination of virulence traits, including the ability to
cross the human placental barrier and cause microcephaly and
other congenital abnormalities2. Like other positive-strand RNA
viruses, ZIKV is highly dependent on host cell machinery for
the production of new virions3,4. The resulting disruption
of cellular networks can directly contribute to clinical disease,
raising the need for system biology methods to elucidate
host–virus interactions within and between all host tissue
compartments5,6.
The development of genome-scale CRISPR/Cas9 knockout
screens has tremendously advanced investigations into genetic
factors that affect disease7. Knockout screens for genes required
for flavivirus-induced cell death have identified a number of novel
targets, including multiple components of the endoplasmic reti-
culum (ER) protein processing and quality-control pathways8,9.
While such screens are powerful tools for elucidating host factors
in infection, they have important limitations: knockouts in genes
that are not essential for virus-induced cell death may escape
detection, as may knockouts in host pathways with genetic or
functional redundancy that can continue to function in the
absence of individual gene products. To date, host factors iden-
tified in gene-editing experiments have thus far clustered around
ER protein complexes essential for flavivirus genome replication
and translation, while metabolic pathways with important roles
during infection have been mostly underrepresented.
ZIKV’s distinct tropism and pathology, and lack of readily
apparent disease mechanism, has prompted efforts to system-
atically map the interaction of ZIKV infection with host cells10.
While studies of the ZIKV-infected host proteome3, tran-
scriptome4,9,11, and protein–protein interactome12 have yielded
new insights into ZIKV biology, the mechanistic basis of ZIKV
pathogenesis remains largely unknown.
Like other flaviviruses, ZIKV carries out each stage of its
replication cycle in close association with cellular membranes,
including the synthesis of new genome copies and assembly of
viral particles within specialized replication complexes (RCs)
formed from extensively remodeled ER membranes13. These
steps appear to require a specific lipid milieu, as flaviviruses
presumably modify various host lipid pathways to create this
milieu14–16. A rapidly growing body of knowledge on the
importance of lipids in cell organization, signaling networks, and
viral disease outcomes therefore led us to investigate how ZIKV
perturbs cellular lipid metabolic networks to establish and pro-
mote infection17,18.
To systematically map the host lipid–virus interaction net-
works in an unbiased manner, we have carried out a global
lipidomic survey in human cells infected with ZIKV or ectopically
expressing NS4B, one of the nonstructural proteins of ZIKV
known to be involved in forming viral replication sites19. We
show that ZIKV infection as well as NS4B expression significantly
alters the lipid composition of human cells, with the most striking
pattern of changes seen within sphingolipids. Ceramide, a
bioactive sphingolipid implicated in signaling and apoptosis, is
recruited to ZIKV replication sites and strongly associates with
ZIKV NS4B. We use pharmacological inhibition and genetic
knockouts of enzymes involved in sphingolipid biosynthesis in
various cell types, including neural progenitor cells, to demon-
strate that sphingolipids are required for ZIKV replication but not
for binding to or entering host cells. Conversely, genetic knockout
of sphingomyelin synthesis drastically increases cellular permis-
siveness to ZIKV, indicating that ceramide or its derivatives,
rather than sphingomyelin, are required for ZIKV infection.
Together, our study identifies a sphingolipid metabolic network
with a novel proviral role in ZIKV replication.
Results
ZIKV alters the lipid landscape of host cells. To understand
how cellular lipid metabolism is altered by ZIKV infection, we
carried out a global lipidomic survey of the model Huh7 human
hepatic carcinoma cell line20 infected for 24 or 48 h with Asian
lineage ZIKV strain FSS13025 (Fig. 1a). Lipids extracted from
populations of mock and infected cells (n= 5 biological replicates
per condition) were analyzed with electrospray ionization tandem
mass spectrometry (LC–ESI–MS/MS) (Supplementary Data 1 and
Supplementary Fig. 1a–f). We identified 340 lipid species span-
ning the phospholipid, sphingolipid, glycerolipid, and sterol
classes for which pairwise comparisons of normalized abundance
between mock and infected cells could be made (Supplementary
Data 1). Of these, 80 species (23.5%) showed significant changes
in abundance by 24 h post infection (hpi) and 172 species (50.6%)
were significantly altered by 48 hpi (P < 0.05, analysis of variance
(ANOVA) or g test) (Supplementary Data 1). Principal compo-
nent analysis (PCA) of these observations confirmed that infec-
tion status (mock or ZIKV) and timepoint (24 or 48 hpi)
accounted for most of these changes, with changes in lipid
composition between mock and infected cells increasing over
time (Fig. 1b).
Next, we examined how ZIKV-induced changes in host lipid
composition broke down by subclass and species (Fig. 1c, d). A
map of the pairwise correlations of all 340 species at 48 hpi
(Supplementary Fig. 2a) revealed that lipid subclasses largely fell
into two groups of species that were either enriched or depleted in
abundance (Supplementary Fig. 2b), suggesting that individual
metabolic pathways are up- or downregulated to create a specific
lipid milieu around the events of the viral replication cycle.
Supporting this, many of the trends we observed were consistent
with earlier reports of functional roles for lipids during flavivirus
infection. In line with evidence that lipid droplets are consumed
as an energy source during flavivirus replication, most triglycer-
ides (TG) declined over the course of infection, though TG
species with 22:6 acyl chains increased. All cholesterol esters were
enriched in ZIKV-infected cells, reproducing trends seen during
dengue virus infection. Trends among phospholipid subclasses
varied: cardiolipin, phosphatidylserine (PS), and phosphatidy-
lethanolamine species were mostly depleted at 24 and 48 hpi, and
phosphatidylcholine species were enriched. A notable exception
was the phosphatidylinositol (PI) subclass, which went from
largely depleted to largely enriched between 24 and 48 hpi. The
role of PI signaling in regulating numerous cellular functions is
well established, and our data support findings that PI pathways
are upregulated to block apoptosis late in flavivirus infection.
Expression of ZIKV NS4B enriches host sphingolipids. The
flavivirus genome encodes three structural (capsid [C], envelope
[E], and membrane [prM]) and seven nonstructural (NS) pro-
teins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5). Structural
ZIKV proteins carry out the entry and membrane fusion steps of
the viral life cycle21, while NS proteins cooperatively remodel ER
membranes to form replication sites and synthesize viral RNA22.
Despite their limited size and number, the functions of most of
the NS proteins are poorly characterized23, as are their interac-
tions with host lipids24 and potentially hundreds of unique pro-
teins3,12,25. While the enigmatic nature of the ZIKV NS proteins
and their interactions presented challenges to defining a
mechanistic basis for our lipidomics results, two lines of evidence
led us to investigate NS4B as potentially important in altering
lipid metabolism. First, NS4B is a transmembrane protein that
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produces the strongest ER stress and autophagic response of the
ten flavivirus proteins when individually expressed26,27, and lipid
metabolism is coordinately regulated with these pathways during
periods of stress28–31. Second, the NS4B of the closely related
Flaviviridae member Hepatitis C virus (HCV) dysregulates lipid
metabolism to permit viral replication32, which may directly
contribute to liver disease33. Like Flavivirus NS4B34, HCV NS4B
is an integral component of the viral RC, and can both remodel
ER membranes into replication site-like structures35 and induce a
potent ER stress response36 when individually expressed.
To examine whether ZIKV NS4B could similarly regulate
global lipid metabolism, we performed a second lipidomic survey
of HEK 293T cells transfected with ZIKV NS4B-FLAG or an
empty vector control (Fig. 2a, Supplementary Fig. 3a–d).
Supporting its role as a major factor in host–virus interactions,
NS4B caused significant downregulation or upregulation (P <
0.05, one-way ANOVA) in 44% of the 318 lipid species identified
relative to the control (Fig. 2b and Supplementary Data 2).
Furthermore, many of these changes were comparable to or
exceeded those of similar species in ZIKV-infected cells, especially
in the negative direction (Fig. 2c).
We analyzed the relationship between NS4B transfection and
ZIKV infection for the set of lipid species (n= 98) that appeared
in both datasets, and found a weak but highly statistically
significant positive correlation between the two conditions (P <
0.05, Pearson correlation coefficient) (Fig. 2d). Strikingly,
ceramides were the only species that were significantly enriched
by over a log in both conditions (Fig. 2d). When we repeated our
analysis for individual lipid classes, sphingolipids were even more
strongly correlated than total lipids, or phospholipids and
glycerolipids alone (Fig. 2e). Together, our results support a
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Fig. 1 Global lipidomics of ZIKV-infected human cells. a Study overview. Huh7 cells were infected with ZIKV strain FSS13025 for 24 or 48 h. Each
experimental condition (Mock 24 hpi, ZIKV 24 hpi, Mock 48 hpi, and ZIKV 48 hpi) had n= 5 replicates for a total of 20 biological samples, 19 of
which were included in our final analysis. b Principal component analysis (PCA) of the lipidomics dataset. Colored arrows represent individual lipid species.
c, d Bubble plots of log2 fold changes in abundance of lipid species in ZIKV-infected cells relative to mock at 24 hpi (c) and 48 hpi (d). Bubble size
represents P value from one-way ANOVA or g test. See also Supplementary Fig. 1, Supplementary Data 1, and the Source Data file.
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P < 0.05 for NS4B and ZIKV 

































































































































Fig. 2 ZIKV NS4B dysregulates host lipid metabolism. a Design of transfection experiment. Total lipids were extracted from HEK 293T cells transfected
with NS4B or an empty vector control; n= 3 biological replicates per condition. b PCA of the lipidomics dataset. Colored arrows represent individual lipid
species. c Bubble plots of log2 fold changes in abundance of lipid species in ZIKV-infected cells relative to mock at 24 hpi. Bubble size represents P value
from one-way ANOVA or g test. d Correlation of log2 fold-change values of lipid species (n= 95) identified in both ZIKV-infection and NS4B-transfection
experiments (see Supplementary Data 1 and 2, respectively). Linear regression best-fit line (y= 0.3212 × 0.02533), R2, and P values are shown. e Pearson’s
correlation coefficient (r) for total or subclasses of lipid pairs. Lines and bars are r values with 95% CI, respectively. See also Supplementary Fig. 3,
Supplementary Data 2, and the Source Data file.
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regulation of sphingolipid metabolism, along with previously
described stress-signaling pathways.
Depletion of cellular sphingolipids inhibits ZIKV propagation.
De novo sphingolipid biosynthesis begins in the ER with the
condensation of L-serine and palmitoyl CoA catalyzed by serine
palmitoyltransferase (SPT) (Fig. 3a). Further reactions yield
dihydrosphingosine, which is converted by ceramide synthase
(CerS) to dihydroceramide, then to ceramide (Cer), the precursor
to SM and other downstream sphingolipids. To determine if
ZIKV could replicate in the absence of sphingolipids, we used the
small-molecule inhibitors myriocin and fumonisin B1 (FB1) to
block the activity of SPT and CerS, respectively (Fig. 3a). Inhi-
bition of sphingolipid synthesis was confirmed by pulse-chase
experiments using the SM precursor [14C]-serine (Supplementary
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treatment effectively reduced overall levels of sphingolipids
without perturbing levels of PS (Supplementary Fig. 4c–f), while
cell growth rate and morphology were not affected (Supple-
mentary Fig. 5a, b).
Next, we examined the ability of ZIKV to propagate in
inhibitor-treated cells. Huh7 cells treated with myriocin or FB1
and infected at a MOI of 0.1 showed a 30-fold reduction in
infectious virions released into the culture supernatant 24 h after
infection, a difference that increased to over 100-fold after 72 h
(Fig. 3b). To control for the possibility that the inhibitors reduced
ZIKV particle infectivity, we performed real-time quantitative
polymerase chain reaction (RT-qPCR) to quantify the number of
ZIKV genomes released into the supernatant of treated and
untreated Huh7 cells (Fig. 3c). Myriocin or FB1 treatment caused
reductions in levels of extracellular viral RNA comparable to the
losses in infectious titer we found by plaque assay, indicating that
inhibition of sphingolipid biosynthesis caused a defect in ZIKV
particle biogenesis. Similarly, propagation of ZIKV in myriocin or
FB1-treated Vero cells, a primate epithelial cell line highly
permissive to flavivirus infection37, resulted in decreased load of E
glycoprotein at 72 hpi (Fig. 3d).
To compare the effects of inhibiting sphingolipid metabolism
to inhibiting other lipid metabolic pathways known to play a role
in the flavivirus replication cycle38, we treated Huh7 cells with
lovastatin (inhibitor of HMGCR, a key enzyme in cholesterol
biosynthesis) or PIK93 (inhibitor of phosphatidylinositol-4-
kinase) before infection with ZIKV; in contrast to myriocin and
FB1, lovastatin treatment caused a more modest 30% decrease in
viral shedding by 24 hpi, and PIK93 did not appear to decrease
infection (Supplementary Fig. 6a, b). We concluded that depletion
of cellular sphingolipids blocked ZIKV propagation in human
and nonhuman primate cells in a manner specific to that
lipid class.
To confirm this finding in a genetic model, we tested ZIKV
propagation in two cell lines negative for SPTLC2: human
haploid HAP1 cells39 with a CRISPR-mediated knockout
(SPTLC2−/−), and knockout murine dendritic DC2.4 cells
(Sptlc2−/−)40. HAP1 cells, which are generally excellent genetic
models for studies of the virus life cycle41–44, yielded a nearly
hundred-fold decrease in viral shedding in SPTLC2GT cells by 48
hpi (Fig. 3e). Though immunocompetent murine cells are highly
restrictive to ZIKV45, we observed a tenfold reduction in ZIKV
production from SPTLC2−/− DC2.4 cells at 24 hpi similar to that
timepoint in our other cell lines (Fig. 3f); both WT and knockout
DC2.4 cells appeared to clear the infection at later timepoints as
previously reported in vivo45, further suggesting that sphingoli-
pids are required for fundamental aspects of flavivirus biology
rather than interactions with specific cell types or antiviral
immunity.
Sphingolipids are required for ZIKV infection of neural pro-
genitor cells. ZIKV is known to be neurotropic and mainly
infects neuronal cells within the central nervous system to cause
microcephaly2. Recent studies have used iPSC-derived human
neural progenitor cells (NPCs) for their studies as a proxy to
physiologically relevant primary cells3,46–48. Therefore, we deci-
ded to use iPSC-derived NPCs to validate our key findings by
manipulating sphingolipid levels in these cells using myriocin and
FB1. Inhibitor-treated cells showed a significantly reduced level of
viral shading as compared with untreated cells, showing roles for
sphingolipids in ZIKV infection in neuronal primary cells
(Fig. 3g). In addition to iPSC-derived NPCs, we also employed
the human neuroblastoma cell line SH-SY5Y to validate our
initial findings further. Consistent with the Huh7 and NPCs, both
myriocin and FB1 significantly reduce the amount of ZIKV
production (Fig. 3h) as compared with the control cells. These
data demonstrate roles for sphingolipid in ZIKV infection and
validate our initial observations.
Sphingolipids are required for ZIKV replication. Both the
sphingolipid metabolic network and flavivirus replication
cycle are distributed throughout the cell, leading us to investigate
where and when the essential ZIKV–sphingolipid interactions
suggested by our inhibitor experiments occur. To test whether
sphingolipids are required for ZIKV binding or entry as has been
reported for other positive-strand RNA viruses49, we incubated
monolayers of Vero cells pretreated with myriocin or FB1 with
~100 ZIKV PFUs on ice for 0–45min, then washed away
unbound virions, and overlaid the cells with methylcellulose
overlay media that did not contain inhibitors. After 3 days, viable
cells were stained with crystal violet, and numbers of plaques
counted (Fig. 4a). Inhibitor-pretreated Vero cells showed no
losses in absolute levels or the rate of plaque formation, indicating
that myriocin inhibition of sphingolipid synthesis did not sig-
nificantly affect ZIKV binding or internalization.
To investigate whether ZIKV requires sphingolipids during
genome replication in the replication factory, we used RT-qPCR
to compare levels of intracellular viral RNA in Huh7 cells treated
with myriocin or FB1 relative to a vehicle control. Supporting the
results of our entry assay, levels of ZIKV RNA bound to cells at 0
hpi were not significantly changed by sphingolipid depletion
(Fig. 4b). After the initiation of RNA replication by 3–4 hpi, levels
of RNA in sphingolipid-depleted cells more than 60% relative to
vehicle-treated cells, remained over 30% lower by 20 hpi (Fig. 4b).
To confirm that these differences were due to decreased RNA
replication rather than defects at other stages of the viral life cycle,
we treated infected sphingolipid-depleted and normal cells with
an inhibitor of ZIKV RNA polymerase (TPB)50, and measured
intracellular replication relative to non-TPB-treated cells at 8 hpi
Fig. 3 Sphingolipids are essential for ZIKV infection. a Overview of sphingolipid biosynthesis. SPT serine palmitoyltransferase, KDSR 3-
ketodihydrosphingosine reductase, DegS delta 4-desaturase, sphingolipid, CerS ceramide synthase, SGMS1 sphingomyelin synthase 1, CERT ceramide
transfer protein. b, c Huh7 cells treated with myriocin, FB1, or a vehicle control were infected with ZIKV (MOI= 0.1). At the indicated times post infection,
culture supernatants were collected and analyzed by plaque assay (b) or RT-qPCR (c); n= 3 independent experiments. Two-way ANOVA with Dunnett’s
multiple-comparison test. d Vero cells treated with myriocin, FB1, or vehicle were infected with ZIKV (MOI= 0.1). At 72 hpi, intracellular levels of ZIKV E
protein were assessed by immunoblotting. Blot is representative of two independent experiments. e, f HAP1 human (e) and DC2.4 murine dendritic (f) WT
and SPTLC2-knockout cells were infected with ZIKV (MOI= 0.1). At the indicated timepoints, culture supernatants were collected and analyzed by plaque
assay; n= 3 independent experiments. Two-way ANOVA with Sidak’s multiple-comparison test (e) and two-tailed Student’s t test (f). g iPSC-derived
human neural progenitor cells (hNPCs) treated with myriocin, FB1, or vehicle were infected with ZIKV (MOI= 0.1). At the indicated times post infection,
culture supernatants were collected and analyzed by plaque assay; n= 6 independent infections. Two-way ANOVA with Tukey’s multiple- comparison
test. h SH-5YSY human neuroblastoma cells were treated with inhibitors, infected with ZIKV (MOI= 0.1), and analyzed by plaque assay. Two-way
ANOVA with Tukey’s multiple-comparison test. Data are mean ± SD. See also Supplementary Data 3, Supplementary Fig. 4, Supplementary Fig. 5, and the
Source Data file.
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(Fig. 4c). ZIKV RNA in both sphingolipid-depleted and vehicle
cells decreased by approximately tenfold under TPB treatment,
ruling out a prereplication viral requirement for sphingolipids.
We concluded that sphingolipids are dispensable for ZIKV entry
into host cells, but are required for viral replication.
The Cer-SM network is a key determinant of ZIKV infection.
Of the thousands of known sphingolipid structures51, which
specific categories of species are required for ZIKV replication?
Our findings that SM and Cer, despite opposing trends during
infection, which are linked by a single enzymatic step in the
sphingolipid metabolic network (Fig. 5a), prompted us to study
their relationship more closely. First, we calculated ratios of
normalized lipid levels for all possible pairs of SM and Cer species
in our dataset (Supplementary Data 4), 382 of which varied sig-
nificantly across experimental conditions (P < 0.01, one-way
ANOVA). We then used recursive feature elimination with
cross-validation (RFECV) to define a subset of 250 lipid pairs
with the features of greatest biological interest (Supplementary
Data 5). PCA of these ratios (Fig. 5b) revealed a pattern of
infection- and time-dependent separation similar to the overall
distribution of lipid species observed previously, indicating that
the SM–Cer metabolic network is strongly perturbed by ZIKV
infection. Furthermore, hierarchical clustering of the lipid pairs
resulted in near-complete separation, as measured by identity of
the nearest neighbor, by ratio type (Cer/Cer, SM/SM, or Cer/SM)
(Fig. 5c). Remarkably, every Cer/SM ratio without exception
decreased from 24 to 48 hpi in mock cells and increased in
infected cells, suggesting that flux between ceramide and SM is
highly regulated during ZIKV replication.
While the trend of ceramide enrichment relative to SM was
consistent across ceramide species, there was considerable
variation among ceramide species in both our ZIKV and NS4B
experiments (Fig. 2d). To identify relationships of biological
interest between ceramide species, we tested RFECV-identified
ratios that fell above the stringent cutoffs of component score >
0.1 and F score > 50. This yielded four Cer/Cer ratios (P < 0.01,
one-way ANOVA) (Fig. 5d–g). Strikingly, each of these high-
interest ratios contained the (dihydro)ceramide Cer(d18:0/16:0)
or Cer(d18:1/16:0), which was the single most enriched lipid by
both ZIKV and NS4B (Fig. 2d). Recently, it has been shown that
the six mammalian ceramide synthases (CERS1–6) preferentially
catalyze the formation of ceramide species with different acyl-
chain lengths and degrees of saturation52,53, and that the
signaling properties of ceramides are influenced by acyl-chain
identity54. Our data indicate that ZIKV infection and NS4B
expression increase the production of Cer(d18:1/16:0) relative to
other ceramide species.
Three major pathways control ceramide levels in mammalian
cells: (1) de novo synthesis in the ER, (2) degradation of SM by a
family of sphingomyelinases (SMases), and (3) salvage of
sphingolipid catabolism products via conversion to sphingosine
(Fig. 5a). Because SM is the most abundant sphingolipid in
mammalian cells and represents a major outlet for newly
synthesized ceramides, we reasoned that flux between SM and
Cer likely contributed to ZIKV-driven increases in Cer/SM ratios.
To test this hypothesis, we infected KBM7 cells bearing a gene-
trap mutation for SGMS1, the major human sphingomyelin
synthase55,56. KBM7 SGMS1GT cells displayed higher Cer/SM
ratios than did WT or reconstituted mutant cells (KBM7
SGMS1GT+ SGMS1), recapitulating the trend seen in the Cer/
SM ratios identified by RFECV57. Indeed, KBM7 SGMS1GT cells
were over 100-fold more permissive to ZIKV infection than WT
or SGMS1GT+ SGMS1 cells (Fig. 6a), suggesting that even
modest increases in pools of intracellular ceramide could
dramatically enhance viral replication.
Having increased virus production by blocking the conversion
of Cer to SM, we predicted that blocking the SMase pathway of
Cer synthesis would have the opposite effect. When treated
with the neutral SMase inhibitor GW4869, infected KBM7
SGMS1GT+ SGMS1 cells displayed a 70% reduction in ZIKV
shedding without altering cell viability, while SGMS1GT cells were
unaffected (Fig. 6b, Supplementary Fig. 7a, b). To validate our
KBM7 experiments in Huh7 cells, we again used GW4869 to
block conversion of SM to Cer, and exogenously added
recombinant SMase to increase Cer flux. GW4869 treatment
reduced viral shedding, and SMase treatment modestly increased
permissiveness to ZIKV infection (Fig. 6c, Supplementary
Fig. 8a–d). Taken with our findings that depletion of all
sphingolipids reduces viral replication (Fig. 6d), these data show
that ZIKV targets the SM–Cer flux to successfully establish
infection in the host cells.
Dysregulation of lipid metabolism contributes to diverse
human diseases58, including sphingolipidoses, such as
Niemann–Pick disease and hereditary sensory neuropathy59,60.
The physical interactions between lipids, proteins, and other
macromolecules are increasingly the focus of efforts to system-
















































































































Fig. 4 Sphingolipids are required for ZIKV replication. a Monolayers of Vero cells pretreated for 3 days with myriocin, FB1, or a vehicle control were
incubated on ice for the indicated times with 100 PFUs before washing and overlay with media without the inhibitors. Plaques were counted after 3 days.
Data are representative of four independent experiments. Two-way ANOVA with Tukey’s multiple-comparison test. b Huh7 cells pretreated for 3 days with
myriocin, FB1, or a vehicle control were infected with ZIKV (MOI= 20). Intracellular ZIKV replication in myriocin or FB1-treated cells was measured at the
timepoints shown and plotted relative to vehicle. n= 3 independent experiments. n= 4 independent experiments. c Huh7 cells treated with inhibitors as in
(b) were pretreated for 24 h with the RNA polymerase inhibitor TPB, infected as before, then maintained in TPB and inhibitor/vehicle-treated media for 8 h.
At 8 hpi, intracellular replication in TPB-treated cells was measured relative to non-TPB-treated cells for each condition. n= 2 independent experiments.
Data are mean ± SD; n.s. not significant, *P < 0.05, **P < 0.01, ***P < 0.001, two-tailed Student’s t test. See also the Source Data file.
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These maps have provided evidence that disorders, which are
unrelated in origin, but similar in phenotype, can share
overlapping patterns of genetic and metabolic perturbations,
forming distinct disease modules within the human
interactome63–65.
Having shown the importance of the sphingolipid network in
ZIKV replication, we asked if it interacted with known disease
modules that were clinically similar to the symptoms of ZIKV
infection. To accomplish this, we built a metabolic network
containing the biosynthesis pathways of each subclass in our
a b
Cer(d18:0/16:0) / Cer(d18:0/24:0)
Mock 24 hpi Mock 48 hpi ZIKV 24 hpi ZIKV 48 hpi
Mock 24 hpi Mock 48 hpi ZIKV 24 hpi ZIKV 48 hpi
Cer(d18:0/16:0) / Cer(d18:1/24:0)
Cer(d18:1/16:0) / Cer(d18:1/24:0)
Mock 24 hpi Mock 48 hpi ZIKV 24 hpi ZIKV 48 hpi
































































































































































































Fig. 5 Targeted regulation of sphingolipid metabolism by ZIKV. a Overview of the ceramide metabolism network. b Ratios of normalized lipid levels were
calculated for all combinations of SM and Cer species in our dataset. Ratios that varied significantly across conditions (n= 382, P < 0.01, one-way ANOVA)
were analyzed with recursive feature elimination with cross-validation, and the resulting high-interest Cer/SM pairs (n= 250) were analyzed with PCA.
c Heatmap of clustered log2 SM/Cer ratios identified in (b). Each column represents a single biological sample. d–g Log2 ratios from (b) that met the
following criteria: PC length > 0.1, F score > 50, and P < 0.01. SM sphingomyelin, Cer ceramide. See also Supplementary Data 4 and the Source Data file.
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lipidomics dataset (Supplementary Fig. 9), then surveyed the
network for metabolites associated with seven Medical Subject
Heading (MeSH) terms selected for their similarity to clinical
outcomes of ZIKV infection66–68. As a consequence of including
all compounds and genes from the constituent lipid biosynthesis
pathways in our metabolic model (Supplementary Data 5), nearly
every node of the resulting disease–metabolite network was a
non-lipid compound capable of participating in other aspects of
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P = 0.005
P = 0.644
Fig. 6 Elevated ceramide levels increase ZIKV infection. a KBM7WT, SGMS1GT, and SGMS1GT+ SGMS1 cells were infected with ZIKV (MOI= 1). At the
indicated timepoints, culture supernatants were collected and titrated by plaque assay; n= 8 biological replicates. Two-way ANOVA with Dunnett’s
multiple-comparison test. b KBM7 SGMS1GT and SGMS1GT+ SGMS1 cells were infected with ZIKV (MOI= 1) and treated with 10 μM GW4869 or vehicle.
At 24 hpi, supernatants were collected and analyzed by plaque assay; n= 6 independent infections. Two-tailed Student’s t test. c Huh7 cells were infected
with ZIKV (MOI= 1) and treated with 10 μM GW4869 or recombinant neutral sphingomyelinase (SMase). At 24 hpi, culture supernatants were analyzed
by plaque assay; n= 2 independent experiments. One-way ANOVA with Dunnett’s multiple-comparison test. dModel of experimental perturbations to the
Cer/SM metabolic network and their effects on ZIKV replication. e Network of associations between disease modules similar to congenital ZIKV syndrome
and lipid metabolism pathways. A metabolic network connecting the lipid subclasses identified by lipidomics was mapped to seven medical subject heading
(MeSH) disease terms selected for their phenotypic similarity to clinical ZIKV syndrome. Nodes represent enzymes, lipids, and other metabolites in lipid
biosynthesis, and gray lines represent reactions. Red nodes are metabolites associated with the MeSH ontologies linked by red lines. f Inset panel showing
the metabolic neighborhood of the sphingolipids sphinganine and sphingosine. Data are mean ± SD. See also Supplementary Figs. 6–8, Supplementary
Data 5, and the Source Data file.
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cellular metabolism (Fig. 6e). Remarkably, however, the two
network nodes with the greatest number of connections to MeSH
disease terms were the sphingosine and sphinganine, which differ
by only a single double bond (Fig. 6f). In addition to forming the
sphingoid bases incorporated into all other sphingolipids,
sphinganine and sphingosine are immediate neighbors of SM
and Cer, with which they can be readily interconverted (Fig. 6f
and Fig. 5a).
Ceramide is redistributed to ZIKV replication membranes. The
set of network perturbations we defined left open the function of
ceramide’s role during ZIKV replication. Our results suggested
that the defects in production of new ZIKV RNA and proteins in
the replication factory (Figs. 3d, 4b, c), rather than their assembly
or maturation (Figs. 3c, 4a), caused reduced viral shedding from
sphingolipid-depleted cells, leading us to hypothesize that cer-
amide was physically recruited to membranes of the ZIKV
replication site. In agreement with our lipidomics results, super-
resolution microscopy revealed a close association between cer-
amide and RC marker NS4B (Fig. 7a, g).
To test whether this NS4B-ceramide recruitment was required
for viral replication or a by-product of bulk membrane remodeling
during infection, we transfected Huh7 cells with biosensors for PI
(4,5)P2 and PI4P, lipids in the upregulated PI signaling pathway
(Figs. 1c, d, 2c), which had previously been indicated to participate
in formation of positive-strand RNA virus replication mem-
branes69. Indeed, PI4P—but not the PM-localized PI(4,5)P2—
colocalized with ZIKV NS4B by 24 hpi (Supplementary Fig. 10a,
b). Having previously found that inhibition of PI phosphorylation
had no effect on ZIKV replication (Supplementary Fig. 6a), we
took these results to show that the recruitment and presence of
ceramide in replication membranes are required for ZIKV
replication in a manner outside of bulk recruitment. As a further
control, we measured overlap between ceramide and E protein,
which is produced at replication sites, but not thought to be
present in replication vesicles; further supporting a specific
function for ceramide in replication vesicles, we observed no
correlation with E protein (Fig. 7b, g)13.
Sphingomyelin is enriched in the trans-Golgi network, PM,
and vesicle transport system70, while the events of ZIKV
replication occur in the ER. Because we had shown that
hydrolysis of SM to ceramide by neutral SMase was partially
responsible for the activity of ceramide during viral replication,
we asked whether SM was recruited to replication sites to serve as
a source of ceramide species during infection. To visualize the
intracellular distribution of SM in mock and infected cells, we
utilized Eqt-SM-GFP, a genetically encoded probe capable of
binding diffuse pools of sphingomyelin70,71. We did not observe
correlation between Eqt-SM-GFP and NS4B or E (Fig. 7c, d, g).
This did not prevent enrichment of ceramide in the ER during
ZIKV infection (Fig. 7e, f, h), suggesting that multiple pathways
in sphingolipid biosynthesis and transport are coopted to support
ZIKV replication.
Discussion
Following the explosive outbreak of Zika virus in South and
Central America and subsequent discovery of a startling array of
novel virulence traits and modes of transmission, system biology
approaches have provided a wealth of insights into the host–virus
interactions underlying ZIKV disease. While these studies have
opened promising avenues for further investigation, a major
limitation is their focus on genetically encoded host factors,
leaving the landscape of ZIKV–host metabolite interactions
relatively uncharacterized. To fill in this gap in knowledge, we
performed a global lipidomic survey in ZIKV-infected human
cells, and found that ZIKV alters cellular sphingolipid metabolism
to selectively increase production of ceramides, which are then
enriched at viral replication sites. We confirmed that this rela-
tionship benefited ZIKV replication through targeted perturba-
tions of sphingolipid metabolism in human neural progenitors
and other cell types, resulting in enrichment or depletion of
certain species, and corresponding increases or decreases in ZIKV
RNA synthesis, virion biogenesis, and viral shedding. In sum-
mary, we have mapped a host–virus wiring diagram of sphin-
golipid metabolism in human cells.
Our findings present several avenues to fill in the circuitry of
this wiring diagram and connect it to other maps of the molecular
factors of ZIKV pathogenesis. From a mechanistic standpoint, it
is now clear that individually expressed ZIKV proteins can reg-
ulate specific cellular processes27,72–77, and that minor changes in
genome sequence can greatly affect ZIKV infectivity and
virulence78–80. We show here that ectopic expression of ZIKV
NS4B, a transmembrane protein integral to the Flaviviridae RC22,
causes changes in sphingolipid metabolism similar to what we
observed during full viral infection, implying a causal relationship
between NS4B and dysregulation of sphingolipid homeostasis. It
is notable that this relationship is specific to sphingolipids, as
other regulations of other lipid classes showed only modest cor-
relations between NS4B and ZIKV infection; future work could
address whether similar links exist for other ZIKV NS proteins
and lipid networks, and the extent to which these mechanisms are
conserved across viral clades.
The biosynthesis, degradation, and intracellular distribution of
ceramides is tightly controlled through a complex regulatory
circuit81–86, including glycosylation to form complex sphingoli-
pids or conversion to the highly abundant sphingomyelin87. We
observed increasing ratios of ceramide to sphingomyelin over the
course of infection, essentially reversing homeostatic trends in
both lipids. To test this experimentally, we infected a KBM7 cell
line containing an inactivating mutation for SGMS1, the enzyme
responsible for most SM synthesis in mammalian cells55,88, and
observed significant enhancement of ZIKV infection in SGMS1GT
cells. Ceramide can be obtained through de novo synthesis in the
ER or directly through the degradation of sphingomyelin by a
family of SMases. We observed that GW4869-mediated inhibition
of SMase activity decreased virus production in genetically
complemented KBM7 SGMS1GT cells, while exogenous addition
of SMase enhanced it; in contrast, uncomplemented KBM7
SGMS1GT cells were unaffected by either treatment. Therefore,
the SMase degradation pathway represents a major pipeline in
ZIKV ceramide recruitment. Further work is required to char-
acterize how other modes of ceramide homeostasis, including
conversion to complex sphingolipids, are coopted by ZIKV.
The challenges of studying lipidomic rather than genetic or
proteomic factors of disease have been discussed in detail89, yet
the results we present here in human cells and by others in the
flavivirus arthropod vector90–92 argue strongly for the equal
importance of lipids in questions of ZIKV pathogenesis. Our
evidence that sphinganine and sphingosine are strongly linked to
diseases with phenotypes that are clinically similar to ZIKV
syndrome further implicates the sphingolipid network as con-
tributing to the molecular processes underlying ZIKV virulence.
Indeed, the role of sphingolipid signaling in regulating cell death,
including during neural development, has been extensively
described93–95. Further work is needed to validate lipidomic
trends during ZIKV infection in clinical samples, as has recently
been shown for Ebola virus96,97. A variety of nontoxic pharma-
cological modulators of sphingolipid metabolism exist, including
one that is FDA-approved, raising the possibility that sphingoli-
pid metabolism could be targeted as part of a host-directed
therapeutic strategy in infected patients98,99.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-17433-9
10 NATURE COMMUNICATIONS |         (2020) 11:3652 | https://doi.org/10.1038/s41467-020-17433-9 | www.nature.com/naturecommunications
Methods
Cell culture and transfections. Huh7, Vero, and HEK 293T cells were maintained
in DMEM; HAP1 cells and KBM7 cells were maintained in IMDM. Both media
contained 10% FBS, 100 units/mL penicillin, 100 µg/mL streptomycin, and 1%
nonessential amino acids. C6/36 cells were maintained in MEM containing 5%
FBS, 100 units/mL penicillin, 100 µg/mL streptomycin, and 1% nonessential amino
acids. Mammalian cell lines were maintained at 37 °C and 5% CO2; C6/36 cells
were maintained at 32 °C and 5% CO2.
Transfections. C-FLAG pcDNA3 plasmids containing ZIKV NS4B were gener-
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Fig. 7 Ceramide redistributes to ZIKV replication sites. Huh7 cells were infected with ZIKV (MOI= 10). At 24 hpi, mock and infected cells were fixed, co-
stained with the indicated antibodies, and visualized with Airyscan superresolution light microscopy. All images are representative of four independent
experiments. a, b Cells were co-stained with antibodies against ceramide and ZIKV replication marker NS4B (a) or E protein (b). c, d Huh7 cells were
transfected with SM-Eqt-GFP immediately following infection, then fixed, stained with antibodies against ceramide and NS4B (c) or E protein (d), and
visualized as before. e, f Mock (e) and infected (f) cells were stained with antibodies against ceramide, NS4B, and the ER marker calnexin. g, h Pearson’s
correlation coefficient was calculated for the indicated pairs of signals (n= 10 cells per condition pooled from four independent experiments; each dot
represents r from a single field of view containing one or more cells). Thick central bar, mean; upper and lower bars, SD. Unpaired two-tailed Student’s
t test. a–f Scale bar, 10 μm.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-17433-9 ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:3652 | https://doi.org/10.1038/s41467-020-17433-9 | www.nature.com/naturecommunications 11
density of 350,000 cells per well in 6-well plates. Transfections were carried out the
next day using Lipofectamine 3000 transfection reagent (Invitrogen) as per the
manufacturer’s suggested protocol, with 5 µg of plasmid DNA used per transfected
well. Wells were transfected with C-flag NS4B vector or with equal quantities of
empty vector. Media was changed 6 h after transfection. After 48 h post transfec-
tion, individual wells were harvested for lipid purification as in the lipidomics
sample preparation protocol. Cells were also fixed with 4% PFA, then stained with
an Alexa Fluor 488-conjugated anti-FLAG antibody (Cell Signaling Technology
#5407) to confirm high levels of transfection efficacy. For experiments with the
Eqt-SM-GFP sphingomyelin probe, GFP-P4M-SidM PI4P probe, and pLNCX-PH-
PLCδ1-GFP PI(4,5)P2 probe, Huh7 cells were seeded on glass coverslips in a 24-
well plate at a density of 25,000 cells per well. Transfections were carried out with
Lipofectamine 3000 transfection reagent according to the manufacturer’s instruc-
tions; at 24 h post transfection, cells were mock-infected or infected with ZIKV.
Stem cells. Human iPSC (XCL-1)100-derived neural progenitor cells (hNPCs) were
purchased commercially (StemCell Technologies, Cat #70901, Lot #17080) and
maintained up to ten passages according to the manufacturer’s instructions. Briefly,
hNPCs were grown on Matrigel-coated culture plates in Neural Progenitor Med-
ium 2 (StemCell Technologies) up to 95–100% confluency, then detached using
Accutase, and seeded at a density of 80,000–100,000 cells/cm2.
Viruses. Zika virus strain FSS1302536 was propagated in C6/36 or Vero cells, and
viral stocks and experimental samples were titrated on Vero cells by plaque assay
(ZIKV) as described previously101.
Infections. For infections of Huh7, Vero, or DC2.4 cells, ZIKV stocks were diluted
to the desired MOI in DMEM or RPMI containing 2% FBS, and added to cells for
1 h at 37 °C and 5% CO2 with constant rocking. The virus-containing supernatants
were then aspirated, and the infected cells washed three times with PBS before
addition of culture media and continued growth under normal conditions until the
desired timepoints. For KBM7 suspension cells, 500,000 cells per replicate were
centrifuged for 5 min at 300×g at room temperature, and resuspended in 1 mL of
IMDM containing 2% FBS and ZIKV. Cells were rocked for 1 h at 37 °C and 5%
CO2 in 6-well plates, then centrifuged as before, and resuspended in PBS three
times. After aspiration of the final wash, cells were resuspended in culture media
and grown under normal conditions until the desired timepoints.
Lipid sample collection. Huh7 cells were seeded at a density of 1.2 million cells in
15-cm dishes and infected the next day with ZIKV FSS13025 at an MOI ~50 PFU/
cell to ensure that all cells were infected. At 24 and 48 hpi, mock and infected cells
were washed three times with ice-cold PBS and detached by scraping. A small
fraction of the cell suspension was retained for protein content determination by
BCA assay (Supplementary Data 1); the remaining volume was transferred into
glass sample tubes on ice and centrifuged for 5 min at 500×g and 4 °C. After
aspiration of the PBS supernatant, cell pellets were resuspended with 1 mL of ice-
cold methanol and stored at −80 °C. Using a modified Folch extraction102,
chloroform and water were added to samples for a final ratio of 8:4:3 chloroform:
methanol:water. The samples were vortexed to mix, chilled on ice for 5 min, and
then vortexed again. The samples were incubated at 4 °C for 2 h to allow for the
separation of the phases. The lower organic lipid-containing layer was removed,
dried in vacuo, and then stored at −20 °C in 2:1 chloroform:methanol (v/v) until
analysis.
LC–MS/MS analysis and lipid identification. LC–MS/MS parameters and iden-
tifications were conducted as outlined103. A Waters Aquity UPLC H class system
interfaced with a Velos-ETD Orbitrap mass spectrometer was used for
LC–ESI–MS/MS analyses. Lipid extracts were dried in vacuo, reconstituted in 10 µl
of chloroform plus 540 µl of methanol, and injected onto a reverse-phase Waters
CSH column (3.0-mm × 150-mm × 1.7-µm particle size), and lipids were separated
over a 34-min gradient (mobile phase A: ACN/H2O (40:60) containing 10 mM
ammonium acetate; mobile phase B: ACN/IPA (10:90) containing 10 mM
ammonium acetate) at a flow rate of 250 µl/min. Samples were analyzed in both
positive and negative ionization modes using higher-energy collision dissociation
and collision-induced dissociation to obtain high coverage of the lipidome. The
fragment ions used for lipid identifications were used as previously outlined103. The
LC–MS/MS raw data files were analyzed using LIQUID whereupon all identifica-
tions were manually validated by examining the fragmentation spectra for diag-
nostic and fragment ions corresponding to the acyl chains. In addition, the
precursor mass isotopic profile and mass ppm error, extracted ion chromatograph,
and retention time for each identification was examined. To facilitate quantification
of lipids, a reference database for lipids identified from the MS/MS data was
created, and features from each analysis were then aligned to the reference database
based on their identification, m/z, and retention time using MZmine 2104. Aligned
features were manually verified, and peak apex-intensity values were exported for
statistical analysis.
QC, normalization, and statistical comparison methods. Data from positive and
negative ion modes were analyzed separately using MATLAB version R2016b
(MathWorks). Any unobserved lipid values were recorded as missing (NAs), and
the data were log2-transformed. The rMd-PAV algorithm105 was used to identify
potential outliers on the basis of their correlation, median absolute deviation, and
skew; confirmation of outlier biological samples was achieved via Pearson corre-
lation between the samples. All lipids were assessed for having at least two
observations across all samples and enough observations for performing either
qualitative or quantitative statistical tests105; none of them failed to meet these
requirements, and thus all lipids were retained for further analysis. The data were
normalized using global median centering, in which each sample was scaled by the
median of its observed abundance values. This approach has been described
previously106–109 and utilized in a number of other studies110–112. Lipids were
evaluated using ANOVA with a Dunnett test correction to compare infected with
mock at each timepoint (24 h and 48 hpi). Yellowbrick113 was used to perform
recursive feature extraction.
Cell culture treatments. Myriocin, FB1, GW4869, lovastatin, and PIK93 were
purchased from Cayman Chemical. Myriocin was dissolved in DMSO to make
15 mM stock solutions, and added to culture media at 1:500 for a final con-
centration of 30 µM; because myriocin is not fully soluble at 15 mM, stocks were
thawed at room temperature, then heated for 15 min at 55 °C immediately before
addition to media. FB1 was dissolved in 1:1 acetonitrile:DI water to make 5 mM
stocks, then added 1:1000 to culture media for a final concentration of 5 µM.
Myriocin and FB1 treatments were carried out for 72 h before experimental
manipulations; we did not observe significant differences in growth rate or mor-
phology over that period (Supplementary Fig. 2). GW4869 was added to culture
media for 24 h at a final concentration of 10 µM, and stocks were prepared as
previously outlined114. No significant toxicity was observed by CellTiter Glo assay
(Promega) (Supplementary Fig. 4). Lovastatin and PIK93 were dissolved in DMSO,
tested negative for cytotoxicity by CellTiter Glo assay, and used to pretreat cells for
24 h before infection at the indicated concentrations (Supplementary Fig. 6). All
inhibitor stocks were stored at −20 °C. Neutral sphingomyelinase from Bacillus
cereus (Sigma-Aldrich) was supplied at 2.5 units/mL (one unit is defined as
hydrolyzing 1 μM of TNPAL-sphingomyelin per min at pH 7.4 and 37 °C) in 50%
glycerol containing 50 mM Tris-HCl, pH 7.5. SMase was diluted in culture media
to a final concentration of 0.1 units/mL and added to cells immediately after
infection with ZIKV before supernatants were collected for titration by plaque
assay at 24 hpi.
Sphingomyelinase activity assay. Huh7 cells were seeded in 96-well plates at a
density of 20,000 cells per well. Cells were treated with GW4869 as described above,
then lysed in PBS with 1% Triton X-100 and 1 mM PMSF. Sphingomyelinase
activity in cell lysates in the presence and absence of 10 μM GW4869 was deter-
mined with the Amplex Red Sphingomyelinase Assay (Invitrogen) as per the
manufacturer’s instructions.
RT-qPCR. To measure intracellular viral replication, Huh7 cells were treated with
30 µM myriocin, 5 µM FB1, or 1:500 (v/v) DMSO for at least 72 h before seeding in
six-well plates (200,000 cells per well). Cells were incubated for 24 h in freshly
treated media containing 20 µM TPB47 (ChemBridge) or an additional DMSO
vehicle control, then infected with ZIKV at a MOI of 20. At 0, 4, 8, 12, and 24 hpi,
cells were lysed with Trizol reagent (Invitrogen) and stored at −80 °C. RNA was
harvested using a Trizol phenol–chloroform extraction according to the manu-
facturer’s protocol, and converted into cDNA with a High-Capacity RNA-to-
cDNA kit (Applied Biosystems) using random hexamers. Real-time PCR was
performed with a StepOnePlus Real-Time PCR system (Applied Biosystems) using
TaqMan primer/probe sets (Thermo Fisher) against ZIKV48 (Assay ID APH6AE9)
and beta-Actin (Assay ID Hs99999903_m1) according to the manufacturer’s
protocol. ZIKV signal was normalized to beta-Actin, and relative comparisons
between treatments were made with the 2−ΔΔCT method115. For measurements of
viral shedding, RNA was isolated from culture supernatants with Trizol according
to the manufacturer’s protocol, and absolute quantification was performed by
constructing a gBlock (IDT) standard curve as described previously116.
Fluorescence microscopy. Huh7 cells were seeded on glass coverslips in 24-well
plates at a density of 20,000 cells per well and grown overnight. The next day, cells
were infected with ZIKV at a MOI of 10 and/or transfected as needed, and grown
another 24 h before fixation with 4% paraformaldehyde in PBS for 15 min at room
temperature. After washing with PBS, cells were blocked/permeabilized in blocking
buffer (10% normal goat serum, 0.1% Triton X-100 in PBS) for 1 h. Incubations
with primary and Alexa Fluor-conjugated secondary antibodies diluted in blocking
buffer (see “Reporting summary” for a list of antibodies and dilution information)
were performed for 1 h at room temperature, separated by three 5-min washes with
PBS. DAPI (4′,6-diamidino-2-phenylindole) was used to visualize nuclei. Cover-
slips were mounted on glass slides with ProLong Glass antifade reagent (Thermo
Fisher). Images were acquired with a Zeiss LSM 880 laser-scanning confocal
microscope in Airyscan mode using a 63×/1.4 NA oil objective. Fluorophores were
excited sequentially by 405-/488-/561-/633-nm lines, and imaging conditions were
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optimized to minimize bleed-through. Z stacks were taken with a 0.18-μm interval
between slices. Airyscan processing was performed in Zeiss Zen software using the
default settings.
Image analysis. Pearson’s correlation coefficients (PCC) were measured from z
stacks in Imaris 9.3.1 (Bitplane) using the included Coloc module, after thresh-
olding the signals to reduce background as indicated in the Source Data. PCC
values were calculated from at least ten cells per condition, pooled from two or
three independent experiments.
Immunoblotting. Vero cells were seeded in 10-cm dishes at a density of 1 million
cells per dish and infected the next day with ZIKV at a MOI of 0.1. At 48 and
72 hpi, cells were washed three times with PBS to remove extracellular virus and
lysed with 1% SDS in PBS, followed by three rounds of heating (95 °C for 5 min)
and manual vortexing to complete lysis. Protein levels were determined on a
NanoDrop spectrophotometer (Thermo Fisher Scientific); equal amounts of pro-
tein were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis,
and transferred to a PVDF membrane (Amersham). Samples were blocked with 5%
dried milk in TBST and probed with monoclonal antibodies for flavivirus E protein
(4G2) (1:500) and GAPDH (1:1,000), followed by incubation for 1 h with HRP-
conjugated secondary antibodies (1:1,000). Blots were visualized with SuperSignal
West Pico chemiluminescent substrate (Thermo Fisher Scientific) on an Image-
Quant LAS 4000 imager (GE Life Sciences).
Binding and entry assay. Vero cells were seeded in six-well plates at approxi-
mately 250,000 cells per well, so they were 80–90% confluent the next day. These
monolayers were washed three times with ice-cold PBS to inhibit endocytosis, and
inoculated with 100 PFUs of ZIKV diluted in ice-cold Opti-MEM containing 2%
FBS (0.5 mL of inoculum per well). Cells and virus were incubated at 4 °C with
rocking. After 0, 10, 20, and 45 min, the inoculums were aspirated, and the cell
layers washed three times with ice-cold PBS before addition of Opti-MEM con-
taining 2% FBS and 1% methylcellulose. Plates were incubated for 3 days at 37 °C
and 5% CO2. After that period, the overlay media was removed through repeated
PBS washes, and the cells were fixed with 4% paraformaldehyde and stained as for
plaque assays as described above.
Metabolite–disease module network. To generate a Cytoscape network model of
the lipid subclasses identified in our lipidomics experiment, we input a curated list
of gene or compound identifiers from KEGG (Supplementary Data 5) into the
MetScape 3 Cytoscape app as previously described117,118. To determine whether
any of the network nodes had been associated in the literature with disorders that
were phenotypically similar to ZIKV syndrome, we used the MetDisease Cytoscape
app119 to query the Metab2MeSH database120 for seven Medical Subject Heading
(MeSH) terms (‘macular degeneration’, ‘optic nerve diseases’, ‘pregnancy compli-
cations’, ‘virus diseases’, ‘brain diseases’, ‘congenital abnormalities’, and ‘testicular
disease’) arbitrarily selected for this purpose.
Flow cytometry. Huh7 cells were seeded at a density of 350,000 cells per well in
six-well plates, then incubated in untreated DMEM or DMEM containing GW4869
at a concentration of 10 μM as above. After 18 h of treatment, Huh7 cells were
harvested for staining and flow cytometry analysis. Cells were washed with PBS,
stained with Zombie Violet Fixable Viability Kit (BioLegend) for 10 min. For
ceramide labeling, cells were fixed with 4% PFA at RT for 15 min, blocked and
permeabilized for 10 min with blocking buffer (FCS 5%, Triton X-100 0.1%, and
PBS), and then stained for 30 min at RT with mouse anti-ceramide primary (1:100
in blocking buffer) and Alexa Fluor 555 anti-mouse secondary (1:100 in blocking
buffer). Alexa Fluor 555 secondary staining was used as an isotype control. All
samples were washed twice with FACS buffer before analysis. Data acquisition was
carried out with BD FACSymphony flow cytometer with CellQuest (BD
Bioscience) software; FlowJo (FlowJo LLC) software was used for data analysis and
figure construction.
Statistics. Analysis of lipidomics datasets was performed as described above. All
other statistical analyses were performed using Prism 8.0 (GraphPad). Unless
otherwise stated, P values are from unpaired two-tailed statistical tests without
adjustments for multiple comparisons, with P < 0.05 considered statistically
significant.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Mass spectrometry datasets have been deposited at the Mass Spectrometry Interactive
Virtual Environment (MassIVE) at the University of California, San Diego under the
accession code MSV000085584 [https://doi.org/10.25345/C5HT4Z]. Source data are
provided with this paper.
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